Consolidation in the Spinal Implant Market
Executive Summary
This is the second big deal in the spinal implant market in the last three months. With its acquisition of Acromed, DePuy establishes itself as a strong Number 2 in what company officials believe is the fastest growing market in orthopedics today. Moreover, it did so at a fraction of the price Sulzer paid to get SpineTech just a couple of years earlier. While industry officials shake their heads at Sulzer's largesse, company officials are betting that SpineTech's cage technology represents a breakthrough product in spinal implants.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.